// App-Quantinova.ai

OP0022 (2022) : DISEASE ACTIVITY-GUIDED TAPERING OF BIOLOGICS IN PATIENTS WITH INFLAMMATORY ARTHRITIS: A RANDOMISED, OPEN-LABEL, EQUIVALENCE TRIAL

Researchers

Presenter

  • L. Uhrenholt

Principal Investigators

  • R. Christensen

  • L. Dreyer

  • E. M. Hauge

  • A. Schlemmer

  • A. G. Loft

  • M. Nyhuus Bendix Rasch

  • H. C. Horn

  • K. Gade

  • P. C. Taylor

  • S. Kristensen

Medical Centers

  • Aalborg University Hospital, Ophthalmology, Aalborg, Denmark

  • Aarhus University, Institute of Clinical Medicine, Aarhus, Denmark

  • The Parker Institue, Bispebjerg and Frederiksberg Hospital, Section for Biostatistics and Evidence-Based Research, Copenhagen, Denmark

  • University of Southern Denmark, Odense University Hospital, Research Unit of Rheumatology, Department of Clinical Research, Odense, Denmark

  • Aarhus university Hospital, Department of Urology, Skejby, Denmark

  • Aarhus University, Institute of Clinical Medicine, Aarhus, Denmark

  • Randers Regional Hospital, Department of Internal Medicine, Rheumatology, Randers, Denmark

  • Odense University Hospital, Department of Hematology, Odense, Denmark

  • Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Oxford, United Kingdom

Locations

  • Denmark

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Musculoskeletal

Disease

  • Inflammatory Arthritis

  • Axial spondyloarthritis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

  • Open Label

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • Bristol Myers Squibb (BMS)

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved